FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Merck, Moderna Developing Personalized Cancer Vaccine

Merck exercises an option to collaborate with Moderna on a personalized cancer vaccine currently being evaluated in a Phase 2 trial.

latest-news-card-1
Medical Devices

Chinese Firm Recalls Unauthorized Covid-19 Tests

Jiangsu Well Biotech (Jiang Su Sheng, China) recalls its Covid-19 Ag Rapid Test Devices because they were distributed without authorization, clearance...

latest-news-card-1
Medical Devices

FDA Launches TAP Pilot

FDA says CDRH is launching the Total Product Life Cycle Advisory Program (TAP) pilot program called for in the MDUFA 5 reauthorization agreement.

latest-news-card-1
Human Drugs

Legacy Pharmaceutical CGMP Violations

FDA warns Earth City, MO-based Legacy Pharmaceutical Packaging about CGMP violations and insanitary conditions in its manufacturing of finished drugs.

latest-news-card-1
Medical Devices

Comment Deadline Extended for LASIK Labeling Guidance

FDA extends the deadline for comments on a draft guidance intended to improve labeling for LASIK devices used in vision correction.

latest-news-card-1
Human Drugs

FDA Loses Court Case Over Generic Minocin

The Washington DC District Court rules against FDA in granting summary judgment to plaintiff Melinta Therapeutics that suspends the approval of a gene...

latest-news-card-1
Human Drugs

FDA Proposes to Deny Hetlioz sNDA

FDA explains why it is proposing to refuse to approve a Vanda sNDA for a new indication for Hetlioz.

latest-news-card-1
Human Drugs

Drug Outsourcing Group/FDA Settle Law Suit

The Outsourcing Facilities Association and FDA reach a settlement agreement that compels the agency to promptly review long-pending nominations for ac...

Medical Devices

Marked Change Seen in FDA Final CDS Guidance

Hyman, Phelps & McNamara attorneys and a medical device regulatory expert say an FDA final guidance on clinical decision support software will generat...

latest-news-card-1
Human Drugs

More Quality Issues at Lilly Plant: Reuters

Reuters reports that FDA has again found quality issues at the Lilly Branchburg, NJ, drug manufacturing facility.